sorafenib,durvalumab,tremelimumab
astrazeneca,pfizer
['hcc', 'himalaya', 'thank you']
thank you to dr george lau of humanity and health medical group for stopping by to discuss outcomes by occurrence and temporal patterns of immune-mediated adverse effects in the himalaya study in unresectable hcc. check out our site to hear more! #asco23 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.